– 2% off the initial fee until 29 June, apply before this date to receive the summer 2021 dividend – Target annual tax free dividend of 4.5% of NAV – Portfolio of entrepreneurial, growth orientated companies across technology, healthcare and creative industries. See portfolio company examples here – Dividend Reinvestment Scheme and monthly standing order available – … Continued
inspiresport is the industry leading sports development tour operator, offering unrivaled access to world class clubs, coaches, and facilities to take young players of all abilities on extraordinary sporting journeys. The company has been acquired by Portman Travel Group, which is expanding into the sports travel market, providing an exit event for Calculus investors. Calculus, … Continued
Cambridge, UK., 13 May 2021 – Arecor Limited (“Arecor” or “the Company”), the biopharmaceutical company advancing today’s therapies to enable healthier lives, today announces the grant by the United States Patent and Trademark Office of U.S. Utility Patent No. 10,925,965 B2, a patent that contributes to the Company’s global patent portfolio underpinning its ArestatTM technology … Continued
The University of Edinburgh spin-out is developing potentially lifesaving products that help reduce complications and high death rates amongst dialysis patients. Incoming institutional investor Calculus Capital has participated in a funding round with existing investors Downing Ventures and Mercia, alongside Solvay Ventures, Scottish Enterprise and Old College Capital Glasgow, Scotland, May 6th, 2021 – Invizius … Continued
Business expansion and appointment of local team will enable Blu Wireless to accelerate growth in the defence, public safety, and transport sectors, providing enhanced customer service in North America. Blu Wireless, the leader in 5G mmWave networking equipment, has today announced the expansion into the United States with the launch of Blu Wireless Technology Inc. … Continued
MIP Diagnostics, which produces synthetic antibodies, has launched a new product that could improve the success of rapid sensors in detecting COVID-19. MIP Diagnostics has today announced the launch of its COVID-19 nanoMIP for diagnostic sensors, a synthetic alternative to antibodies that offers ultra-high sensitivity for the next wave of COVID-19 antigen detecting devices. nanoMIPs … Continued
The licensing agreement, which C4X will receive an upfront payment of €7 million from, is for their oral pre-clinical IL-17A inhibitor programme. 12 April 2021 – C4X Discovery Holdings plc (AIM: C4XD), a pioneering Drug Discovery company, announces that its subsidiary, C4X Discovery Limited (“C4XD”, “C4X Discovery” or the “Company”), has signed an exclusive worldwide licensing agreement with … Continued
Coveted award for Phase II clinical development of lead product, AT247, its next generation ultra-rapid acting Insulin Cambridge, UK., 31st Mar 2021: Arecor Limited (“Arecor” or “the Company”), the biopharmaceutical company advancing today’s therapies to enable healthier lives, today announces that it has been awarded a £2.8 million grant from Innovate UK to support the … Continued
ActiveOps admitted to trading on AIM today IPO to pay out £21 million to Calculus investors Calculus Capital portfolio company ActiveOps has completed a successful Initial Public Offering on the Alternative Investment Market, generating an impressive 6x return for Calculus EIS investors. ActiveOps has placed 45 million shares with institutional investors, raising gross proceeds of … Continued
Biotech sector-leaders combine tools, talent, and technologies to drive life science discovery forward Merger accompanied by £3.8million ($5.3m USD) investment across existing shareholders and new investors, which will be used to fund recruitment and growth of the business Axol Bioscience Ltd, an established provider of stem cells produced from reprogrammed human blood and tissue cells, … Continued